Literature DB >> 11188992

Successful treatment of Paecilomyces lilacinus endophthalmitis after foreign body trauma to the cornea.

Y Domniz1, M Lawless, G L Sutton, C M Rogers, L J Meagher.   

Abstract

PURPOSE: To report the successful treatment of a patient with Paecilomyces lilacinus endophthalmitis infection after foreign body (FB) trauma to the cornea.
METHODS: A 30-year-old man presented to us with a corneal abscess and iritis 2 months after removal of a metal corneal FB. Initial corneal biopsy culture was negative. Treatment with topical 5% natamycin, 0.9% fortified gentamycin, and 5% cephalothin hourly was commenced. As a result of developing signs of endophthalmitis, two more biopsies were taken, a week apart, from the vitreous and anterior chamber, successively. The last biopsy yielded positive microbiologic results of the specious Paecilomyces lilacinus. Intravitreal injection of 50 microg/0.5 mL of amphotericin was administered during the vitreal biopsy. Soon after isolating the specious Paecilomyces lilacinus, the following treatment was administered: 200 mg of itraconazole bd by mouth, 5% topical natamycin every hour, 2 mg/mL of topical fluconazole every 2 hours, three anterior chamber injections of 0.35 mL of 0.1% fluconazole and two amphotericin B injections to the anterior chamber of 50 microg/0.5 mL each.
RESULTS: There appeared to be no sign of infection 6 months after initial treatment. A large, dense scar existed in the medial part of the cornea only. The pupil was secluded. The patient's visual acuity was 6/21. The eye was comfortable and all topical antifungal medication was ceased.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11188992     DOI: 10.1097/00003226-200101000-00021

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  2 in total

1.  Recalcitrant Paecilomyces keratitis.

Authors:  Seetha Lakshmi; Cristina Vanessa Garcia
Journal:  BMJ Case Rep       Date:  2019-04-24

2.  [Invasive mycoses and trauma].

Authors:  Alexandra Obradovic; Stefan Hajdu; Elisabeth Presterl
Journal:  Wien Med Wochenschr       Date:  2007
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.